HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (43) Citing Articles via Google Scholar Google Scholar Articles by Bouwens, L. Articles by Rooman, I. Search for Related Content PubMed PubMed Citation Articles by Bouwens, L. Articles by Rooman, I.

Regulation of Pancreatic Beta-Cell Mass

Cell Differentiation Unit, Vrije Universiteit Brussel-Free University of Brussels, Brussels, Belgium

Beta-cell mass regulation represents a critical issue for understanding diabetes, a disease characterized by a near-absolute (type 1) or relative (type 2) deficiency in the number of pancreatic beta cells. The number of islet beta cells present at birth is mainly generated by the proliferation and differentiation of pancreatic progenitor cells, a process called neogenesis. Shortly after birth, beta-cell neogenesis stops and a small proportion of cycling beta cells can still expand the cell number to compensate for increased insulin demands, albeit at a slow rate. The low capacity for self-replication in the adult is too limited to result in a significant regeneration following extensive tissue injury. Likewise, chronically increased metabolic demands can lead to beta-cell failure to compensate. Neogenesis from progenitor cells inside or outside islets represents a more potent mechanism leading to robust expansion of the beta-cell mass, but it may require external stimuli. For therapeutic purposes, advantage could be taken from the surprising differentiation plasticity of adult pancreatic cells and possibly also from stem cells. Recent studies have demonstrated that it is feasible to regenerate and expand the beta-cell mass by the application of hormones and growth factors like glucagon-like peptide-1, gastrin, epidermal growth factor, and others. Treatment with these external stimuli can restore a functional beta-cell mass in diabetic animals, but further studies are required before it can be applied to humans.

This article has been cited by other articles:

				P. Bertolino, R. Holmberg, E. Reissmann, O. Andersson, P.-O. Berggren, and C. F. Ibanez Activin B receptor ALK7 is a negative regulator of pancreatic {beta}-cell function PNAS, May 20, 2008; 105(20): 7246 - 7251. [Abstract] [Full Text] [PDF]

				P. D. Hardt, M. D. Brendel, H. U. Kloer, and R. G. Bretzel Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed? Diabetes Care, February 1, 2008; 31(Supplement_2): S165 - S169. [Abstract] [Full Text] [PDF]

				H. Mziaut, S. Kersting, K.-P. Knoch, W.-H. Fan, M. Trajkovski, K. Erdmann, H. Bergert, F. Ehehalt, H.-D. Saeger, and M. Solimena ICA512 signaling enhances pancreatic -cell proliferation by regulating cyclins D through STATs PNAS, January 15, 2008; 105(2): 674 - 679. [Abstract] [Full Text] [PDF]

				J. Movassat and B. Portha Early administration of keratinocyte growth factor improves {beta}-cell regeneration in rat with streptozotocin-induced diabetes J. Endocrinol., November 1, 2007; 195(2): 333 - 340. [Abstract] [Full Text] [PDF]

				S. Chen, S. Turner, E. Tsang, J. Stark, H. Turner, A. Mahsut, K. Keifer, M. Goldfinger, and M. K. Hellerstein Measurement of pancreatic islet cell proliferation by heavy water labeling Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1459 - E1464. [Abstract] [Full Text] [PDF]

				J. Jo, M. Y. Choi, and D.-S. Koh Size Distribution of Mouse Langerhans Islets Biophys. J., October 15, 2007; 93(8): 2655 - 2666. [Abstract] [Full Text] [PDF]

				C. E. Gleason, D. N. Gross, and M. J. Birnbaum When the usual insulin is just not enough PNAS, May 22, 2007; 104(21): 8681 - 8682. [Full Text] [PDF]

				R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells J. Biol. Chem., April 20, 2007; 282(16): 12030 - 12037. [Abstract] [Full Text] [PDF]

				B. Ahren Insulin Secretion and Insulin Sensitivity in Relation to Fasting Glucose in Healthy Subjects Diabetes Care, March 1, 2007; 30(3): 644 - 648. [Abstract] [Full Text] [PDF]

				H. Jiang, H. Zhu, X. Chen, Y. Peng, J. Wang, F. Liu, S. Shi, B. Fu, Y. Lu, Q. Hong, et al. TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin Diabetes, January 1, 2007; 56(1): 49 - 56. [Abstract] [Full Text] [PDF]

				L. G. Moss and C. J. Rhodes {beta}-Cell Regeneration: Epithelial Mesenchymal Transition Pre-EMTpted by Lineage Tracing? Diabetes, January 1, 2007; 56(1): 281 - 282. [Full Text] [PDF]

				P. J. Miettinen, J. Ustinov, P. Ormio, R. Gao, J. Palgi, E. Hakonen, L. Juntti-Berggren, P.-O. Berggren, and T. Otonkoski Downregulation of EGF Receptor Signaling in Pancreatic Islets Causes Diabetes Due to Impaired Postnatal {beta}-Cell Growth Diabetes, December 1, 2006; 55(12): 3299 - 3308. [Abstract] [Full Text] [PDF]

				M. Mimeault and S. K. Batra Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies Stem Cells, November 1, 2006; 24(11): 2319 - 2345. [Abstract] [Full Text] [PDF]